CVS Health profit beats on higher prescription drug sales

(Reuters) – Drugstore retailer CVS Health Corp (CVS.N) beat analyst estimates for adjusted quarterly profit on Wednesday as it sold more prescription drugs at its stores.

FILE PHOTO A logo of CVS Health is displayed on a monitor above the floor of the New York Stock Exchange shortly after the opening bell in New York, U.S., December 5, 2017. REUTERS/Lucas Jackson/File Photo

CVS, which agreed to buy health insurer Aetna (AET.N) in a $69 billion deal in December, said it now expects the deal to close during the third quarter or early in the fourth quarter of 2018.

The Aetna deal is likely to…

Read More Here

Be the first to comment on "CVS Health profit beats on higher prescription drug sales"

Leave a comment

Your email address will not be published.